151 related articles for article (PubMed ID: 1489197)
1. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
Arika T; Yokoo M; Yamaguchi H
Antimicrob Agents Chemother; 1992 Nov; 36(11):2523-5. PubMed ID: 1489197
[TBL] [Abstract][Full Text] [Related]
2. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
Arika T; Yokoo M; Maeda T; Amemiya K; Yamaguchi H
Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
[TBL] [Abstract][Full Text] [Related]
3. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
Uchida K; Kudoh M; Yamaguchi H
Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
[TBL] [Abstract][Full Text] [Related]
4. Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
Syed TA; Maibach HI
Expert Opin Pharmacother; 2000 Mar; 1(3):467-73. PubMed ID: 11249531
[TBL] [Abstract][Full Text] [Related]
5. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
[TBL] [Abstract][Full Text] [Related]
6. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
Tschen E; Elewski B; Gorsulowsky DC; Pariser DM
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199
[TBL] [Abstract][Full Text] [Related]
7. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.
Arika T; Yokoo M; Hase T; Maeda T; Amemiya K; Yamaguchi H
Antimicrob Agents Chemother; 1990 Nov; 34(11):2250-3. PubMed ID: 2073116
[TBL] [Abstract][Full Text] [Related]
8. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
Tatsum Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):425-32. PubMed ID: 12222928
[TBL] [Abstract][Full Text] [Related]
9. Butenafine.
McNeely W; Spencer CM
Drugs; 1998 Mar; 55(3):405-12; discussion 413. PubMed ID: 9530545
[TBL] [Abstract][Full Text] [Related]
10. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
Reyes BA; Beutner KR; Cullen SI; Rosen T; Shupack JL; Weinstein MB
Int J Dermatol; 1998 Jun; 37(6):450-3. PubMed ID: 9646136
[No Abstract] [Full Text] [Related]
11. Topical butenafine for tinea pedis.
Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
[No Abstract] [Full Text] [Related]
12. Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent.
Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
Antimicrob Agents Chemother; 1995 Oct; 39(10):2353-5. PubMed ID: 8619597
[TBL] [Abstract][Full Text] [Related]
13. Butenafine: an update of its use in superficial mycoses.
Gupta AK
Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
Saple DG; Amar AK; Ravichandran G; Korde KM; Desai A
J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116
[TBL] [Abstract][Full Text] [Related]
15. Butenafine and superficial mycoses: current status.
Singal A
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
[TBL] [Abstract][Full Text] [Related]
16. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929
[TBL] [Abstract][Full Text] [Related]
17. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
Tanuma H; Doi M; Ohta Y; Abe M; Kume H; Mukai H; Katsuoka K
Mycoses; 2001; 44(7-8):287-99. PubMed ID: 11714064
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs.
Itoyama T; Uchida K; Yamaguchi H; Fujita S
J Antimicrob Chemother; 1997 Sep; 40(3):441-4. PubMed ID: 9338501
[TBL] [Abstract][Full Text] [Related]
19. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis.
Koga H; Nanjoh Y; Kaneda H; Yamaguchi H; Tsuboi R
Antimicrob Agents Chemother; 2012 Jun; 56(6):3138-43. PubMed ID: 22391525
[TBL] [Abstract][Full Text] [Related]
20. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.
Uchida K; Tanaka T; Yamaguchi H
Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
